A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Washington University School of Medicine
Ossium Health, Inc.
New York Medical College
xCures
Sanguine Biosciences
Hospital Universitari Vall d'Hebron Research Institute